Jon Lieber | CFO |
Adam Gridley | President and CEO |
Don Haut | Chief Business Officer |
Lynne Kelley | Chief Medical Officer |
Stephen Kennedy | COO |
Chad Messer | Needham & Company |
Josh Jennings | Cowen |
Ryan Zimmerman | BTIG |
Swayampakula Ramakanth | H.C. Wainwright |
Good morning, and welcome to the Histogenics Second Quarter 2018 Financial and Operating Results Conference Call. At this time all participants are in a listen only mode. Later we’ll conduct the question-and-answer session and instructions will follow at that time. [Operator Instructions] I would now like to turn the call over to Jon Lieber, CFO of Histogenics. Please go ahead.